SCHEMBL3583573

SCHEMBL3583573

NCNC(=O)[CH]COCc1ccccc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PARP1 P09874 1/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
MAPK8 P45983 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3586818 0.90 ALDH1A1 (0.35) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3893971 0.83 MEN1 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3579083 0.76 MEN1 (0.39) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL4981766 0.74 KDM4E (0.42) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3577605 0.74 MEN1 (0.37) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL5759430 0.73 MEN1 (0.39) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3591420 0.73 MEN1 (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3591721 0.73 MEN1 (0.37) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL14273091 0.71 SMN1; SMN2 (0.46) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL3580531 0.70 KDM4E (0.44) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 Wurster, Siegfried (FI) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 SSTR1, SSTR4, SSTR3 KDM4E 1818/4885ALDH1A1 3963/4885HPGD 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.